| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avidity Biosciences, Inc. (RNA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. RNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 283.4K | $3.67M | - | |
| Other | 205.0K | $2.65M | - | |
| Other | 116.9K | $1.51M | - | |
| Other | 91.6K | $1.19M | - | |
| Other | 79.0K | $1.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2024 | Levin Arthur A | Director | Sale+OE | 5,000 | $45.01 | $225,069.00 | -25.2% | |
| Jul 9, 2024 | Boyce Sarah | President And CEO | Sale+OE | 28,000 | $39.93 | $1,118,082.00 | -12.0% | |
| Jun 20, 2024 | Levin Arthur A | Director | Sale+OE | 5,000 | $37.59 | $187,950.50 | -25.2% | |
| Jun 18, 2024 | McCarthy Teresa | Chief Human Resources Officer | Sell | 9,864 | $39.13 | $385,972.40 | -23.5% | |
| Jun 18, 2024 | MacLean Michael F | Chief Financial Officer | Sell | 11,228 | $39.13 | $439,344.90 | -16.3% | |
| Jun 18, 2024 | Boyce Sarah | President And CEO | Sell | 32,074 | $39.13 | $1,255,039.58 | -18.4% | |
| Jun 18, 2024 | Flanagan W. Michael | Csto | Sell | 10,106 | $39.13 | $395,444.75 | -16.6% | |
| Jun 14, 2024 | Boyce Sarah | President And CEO | Sale+OE | 300,000 | $38.63 | $11,588,305.84 | -47.1% | |
| Jun 13, 2024 | Levin Arthur A | Director | Sell | 100,000 | $38.07 | $3,807,410.00 | -21.4% | |
| Jun 12, 2024 | MacLean Michael F | Chief Financial Officer | Sale+OE | 104,245 | $35.72 | $3,723,141.45 | -70.3% |